Cadrenal Therapeutics, Inc. SEC filings CVKD
Cadrenal Therapeutics, Inc. has 277 filings in SEC EDGAR's recent list, going back to Jul 15, 2022. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 7, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 29, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 31, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 21, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2026 | Jul 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 10, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 1, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2026 | May 28, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Apr 1, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Other events
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 16, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 11, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Dec 1, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 24, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Sep 15, 2025 | Sep 12, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Other events
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 18, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Other events
|
Apr 17, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 4, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 7, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Nov 4, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 25, 2024 | Sep 25, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 5, 2024 | Sep 5, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 20, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 16, 2024 | Aug 16, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 31, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Other events
|
May 9, 2024 | May 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 9, 2024 | Apr 9, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 12, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 5, 2024 | Mar 5, 2024 |
| 8-K/A |
Amended current report
Listing notice
|
Feb 15, 2024 | Sep 6, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 12, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Oct 23, 2023 | Oct 20, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 8, 2023 | Sep 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 18, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Other events
|
Aug 16, 2023 | Aug 15, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 24, 2023 | Jul 23, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 14, 2023 | Jul 12, 2023 |
| 8-K |
Current report
Officer or director change
|
May 26, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Jan 25, 2023 | Jan 19, 2023 |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CVKD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ponte Vedra, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1937993
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.